Gefitinib (ZD1839) as compassionate use therapy in patients (pts) with advanced non-small-cell-lung-cancer (NSCLC) after failing prior chemotherapy
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7324-7324
Keyword(s):